Icon

TAXOL (nda020262)- (6MG/ML)

PACLITAXEL HQ SPCLT PHARMA
6MG/ML
Yes No
2013-Mar-09 Expired
None None
None No
TAXOL is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, TAXOL is indicated in combination with cisplatin. TAXOL is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy.
9 0 6
Total Other Developers 1
Drugs with Suitability No
6MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ****** ************ *.*. *********** ******** *, *******, **** **, *********** (***) ***
****** ******* ******* ********* *** *** *********** *-** ***** **, ********, ******** ****, ********* (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** *** *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** * & **** **, ***** *, ***** *, ************* ******* ******** **** (**** ), *******, *************, ****** ******* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** ****** **. **,** *** **, *******, ****** *****, **********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.